UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma

Allergy (Copenhagen), 2018-02, Vol.73 (2), p.490-497

2018

Volltextzugriff (PDF)

P144 Exacerbation-free asthma in children treated with omalizumab

Annals of allergy, asthma, & immunology, 2016-11, Vol.117 (5), p.S63-S64

2016

Volltextzugriff (PDF)

P147 Omalizumab reduces healthcare resource use in children

Annals of allergy, asthma, & immunology, 2016-11, Vol.117 (5), p.S64-S65

2016

Volltextzugriff (PDF)

O020 Asthma exacerbations and lung function decline in children during a 52-week controlled trial of omalizumab

Annals of allergy, asthma, & immunology, 2016-11, Vol.117 (5), p.S7-S8

2016

Volltextzugriff (PDF)

IMPACT OF BASELINE ANGIOEDEMA AND IGE ON RESPONSE TO OMALIZUMAB IN CHRONIC SPONTANEOUS URTICARIA

Annals of allergy, asthma, & immunology, 2023-11, Vol.131 (5), p.S35-S35

2023

Volltextzugriff (PDF)

Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience

Journal of allergy and clinical immunology, 2017-05, Vol.139 (5), p.1431-1444

2017

Volltextzugriff (PDF)

TIME TO CLINICALLY MEANINGFUL RESPONSE TO OMALIZUMAB IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA

Annals of allergy, asthma, & immunology, 2022-11, Vol.129 (5), p.S26-S27

2022

Volltextzugriff (PDF)

PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA MAY BENEFIT FROM LONGER TREATMENT OR UPDOSING WITH OMALIZUMAB

Annals of allergy, asthma, & immunology, 2022-11, Vol.129 (5), p.S10-S10

2022

Volltextzugriff (PDF)

IMPACT OF BASELINE CHARACTERISTICS ON LONG-TERM RESPONSE FOLLOWING OMALIZUMAB TREATMENT IN PATIENTS WITH ALLERGIC ASTHMA

Annals of allergy, asthma, & immunology, 2023-11, Vol.131 (5), p.S53-S53

2023

Volltextzugriff (PDF)

EFFECT OF SEX ON RESPONSE TO OMALIZUMAB IN PATIENTS WITH ASTHMA

Annals of allergy, asthma, & immunology, 2022-11, Vol.129 (5), p.S38-S39

2022

Volltextzugriff (PDF)

IMPROVEMENTS IN SELECT PATIENT-REPORTED OUTCOMES ARE SIMILAR ACROSS DIFFERENT OMALIZUMAB DOSING REGIMENS

Annals of allergy, asthma, & immunology, 2022-11, Vol.129 (5), p.S39-S39

2022

Volltextzugriff (PDF)

C38 UNDERSTANDING THERAPEUTICS IN IPF: Effect Of Pirfenidone On A Novel Definition Of Progression-Free Survival (pfs) In Patients With Idiopathic Pulmonary Fibrosis (ipf): Pooled Analysis From Phase Iii Trials

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

C38 UNDERSTANDING THERAPEUTICS IN IPF: Pirfenidone In Patients Aged 80 Years And Older With Idiopathic Pulmonary Fibrosis (ipf): Safety Findings From Pooled Trial Databases

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

C38 UNDERSTANDING THERAPEUTICS IN IPF: Quartile Forced Vital Capacity Changes At 3, 6, 9, And 12 Months With Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis: A Pooled Phase Iii Analysis

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

The New England journal of medicine, 2005-09, Vol.353 (13), p.1332-1341

2005

Volltextzugriff (PDF)

C31 CLINICAL ASTHMA I: Exploring Omalizumab In Allergic Asthma: An Analysis Of Efficacy By Asthma Severity And Eosinophilic Status Using Pivotal Trial Studies

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

C26 ASTHMA IN INFANTS AND CHILDREN: The Effect Of Omalizumab On Lung Function In Adolescents With Moderate-To-Severe Allergic Asthma

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

C38 UNDERSTANDING THERAPEUTICS IN IPF: Global Safety Analysis Of Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis: Pooled Long-Term Results From Two Real-World Studies

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

Quartile forced vital capacity changes at 3, 6, 9 and 12 months with pirfenidone in patients with Idiopathic Pulmonary Fibrosis: a pooled phase III analysis

Pneumologie (Stuttgart, Germany), 2018, Vol.72 (S 01), p.S27-S28

2018

Volltextzugriff (PDF)

D21 ASTHMA TREATMENT: GLUCOCORTICOIDS, BIOLOGICALS AND BEYOND:Baseline Ige Levels As A Marker Of Type 2 Asthma Among Patients Enrolled In The Prospective Observational Study To Evaluate Predictors Of Clinical Effectiveness In Response To Omalizumab (prospero)

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

C47 ASTHMA AND COPD: ETIOLOGY, MORBIDITY, AND MORTALITY: Asthma-Related Health Outcomes Over Two Years Among Patients Discontinuing Omalizumab In Excels

American journal of respiratory and critical care medicine, 2014-01, Vol.189, p.1

2014

Volltextzugriff (PDF)

C26 ASTHMA IN INFANTS AND CHILDREN: Decreased Exacerbations And Hospitalizations In Adolescents Enrolled In Prospero (prospective Observational Study To Evaluate Predictors Of Clinical Effectiveness In Response To Omalizumab)

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

A31 SEVERE ASTHMA PATHOGENESIS AND TREATMENT STRATEGIES: Evaluating Xolair Persistency Of Response After Long-Term Therapy (xport)

American journal of respiratory and critical care medicine, 2014-01, Vol.189, p.1

2014

Volltextzugriff (PDF)

The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria

Journal of allergy and clinical immunology, 2018-03, Vol.141 (3), p.1138-1139.e7

2018

Volltextzugriff (PDF)

Ultrastructural visualization of 3D chromatin folding using volume electron microscopy and DNA in situ hybridization

Nature communications, 2020-05, Vol.11 (1), p.2120-2120, Article 2120

2020

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(49)
Tagungsberichte
(1)

Sprache

Englisch
(50)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Asthma
(14)
Allergy And Immunology
(12)
Life Sciences & Biomedicine
(11)
Humans
(10)
Monoclonal Antibodies
(10)
Allergy
(7)
Female
(7)
Immunoglobulin E
(7)
Immunology
(7)
Male
(7)
Adult
(6)
Clinical Trials
(6)
Immunotherapy
(6)
Middle Aged
(6)
Patients
(6)
Anti-Asthmatic Agents - Therapeutic Use
(5)
Asthma - Drug Therapy
(5)
Omalizumab
(5)
Omalizumab - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma

P144 Exacerbation-free asthma in children treated with omalizumab

P147 Omalizumab reduces healthcare resource use in children

O020 Asthma exacerbations and lung function decline in children during a 52-week controlled trial of omalizumab

IMPACT OF BASELINE ANGIOEDEMA AND IGE ON RESPONSE TO OMALIZUMAB IN CHRONIC SPONTANEOUS URTICARIA

Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience

TIME TO CLINICALLY MEANINGFUL RESPONSE TO OMALIZUMAB IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA

PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA MAY BENEFIT FROM LONGER TREATMENT OR UPDOSING WITH OMALIZUMAB

IMPACT OF BASELINE CHARACTERISTICS ON LONG-TERM RESPONSE FOLLOWING OMALIZUMAB TREATMENT IN PATIENTS WITH ALLERGIC ASTHMA

EFFECT OF SEX ON RESPONSE TO OMALIZUMAB IN PATIENTS WITH ASTHMA

IMPROVEMENTS IN SELECT PATIENT-REPORTED OUTCOMES ARE SIMILAR ACROSS DIFFERENT OMALIZUMAB DOSING REGIMENS

C38 UNDERSTANDING THERAPEUTICS IN IPF: Effect Of Pirfenidone On A Novel Definition Of Progression-Free Survival (pfs) In Patients With Idiopathic Pulmonary Fibrosis (ipf): Pooled Analysis From Phase Iii Trials

C38 UNDERSTANDING THERAPEUTICS IN IPF: Pirfenidone In Patients Aged 80 Years And Older With Idiopathic Pulmonary Fibrosis (ipf): Safety Findings From Pooled Trial Databases

C38 UNDERSTANDING THERAPEUTICS IN IPF: Quartile Forced Vital Capacity Changes At 3, 6, 9, And 12 Months With Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis: A Pooled Phase Iii Analysis

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

C31 CLINICAL ASTHMA I: Exploring Omalizumab In Allergic Asthma: An Analysis Of Efficacy By Asthma Severity And Eosinophilic Status Using Pivotal Trial Studies

C26 ASTHMA IN INFANTS AND CHILDREN: The Effect Of Omalizumab On Lung Function In Adolescents With Moderate-To-Severe Allergic Asthma

C38 UNDERSTANDING THERAPEUTICS IN IPF: Global Safety Analysis Of Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis: Pooled Long-Term Results From Two Real-World Studies

Quartile forced vital capacity changes at 3, 6, 9 and 12 months with pirfenidone in patients with Idiopathic Pulmonary Fibrosis: a pooled phase III analysis

D21 ASTHMA TREATMENT: GLUCOCORTICOIDS, BIOLOGICALS AND BEYOND:Baseline Ige Levels As A Marker Of Type 2 Asthma Among Patients Enrolled In The Prospective Observational Study To Evaluate Predictors Of Clinical Effectiveness In Response To Omalizumab (prospero)

C47 ASTHMA AND COPD: ETIOLOGY, MORBIDITY, AND MORTALITY: Asthma-Related Health Outcomes Over Two Years Among Patients Discontinuing Omalizumab In Excels

C26 ASTHMA IN INFANTS AND CHILDREN: Decreased Exacerbations And Hospitalizations In Adolescents Enrolled In Prospero (prospective Observational Study To Evaluate Predictors Of Clinical Effectiveness In Response To Omalizumab)

A31 SEVERE ASTHMA PATHOGENESIS AND TREATMENT STRATEGIES: Evaluating Xolair Persistency Of Response After Long-Term Therapy (xport)

The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria

Ultrastructural visualization of 3D chromatin folding using volume electron microscopy and DNA in situ hybridization

Suchergebnisse filtern